adenosine has been researched along with Dyspnea in 57 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (3.51) | 18.2507 |
| 2000's | 14 (24.56) | 29.6817 |
| 2010's | 40 (70.18) | 24.3611 |
| 2020's | 1 (1.75) | 2.80 |
| Authors | Studies |
|---|---|
| Aribal, S | 1 |
| Enriquez, A; Frankel, DS | 1 |
| Crea, F; De Vita, A; Filice, M; Lamendola, P; Lanza, GA; Manfredonia, L; Villano, A | 1 |
| Danielak, D; Główka, F; Karaźniewicz-Łada, M | 1 |
| Akkerhuis, KM; Ariotti, S; Brugaletta, S; Karagiannis, A; Ortega-Paz, L; Valgimigli, M; Windecker, S | 1 |
| Andersson, J; Braun, OÖ; Heller, S; Henriksson, P; James, S; Lauermann, J; Lindholm, D; Öhagen, P; Varenhorst, C | 1 |
| Boudewijn, IM; Cox, CA; Farenhorst, MP; Frijlink, HW; Hagedoorn, P; Kerstjens, HAM; Lexmond, AJ; Schokker, S; Ten Hacken, NHT; van den Berge, M; Vonk, JM; Vroegop, SJ | 1 |
| Burla, MJ; Jurvis, A | 1 |
| Berman, DS; Friedman, JD; Gransar, H; Hayes, SW; Min, J; Rozanski, A; Thomson, LE | 1 |
| Belchikov, YG; Dipasquale, EM; Koenig, SJ | 1 |
| Corvol, JC; Demoule, A; Fiamma, MN; Morélot-Panzini, C; Raux, M; Similowski, T; Willer, JC | 1 |
| DiNicolantonio, JJ; Serebruany, VL; Sibbing, D | 1 |
| Jover, E; Tello-Montoliu, A; Valdés, M | 1 |
| Deng, J; Han, Y; Li, S; Wang, X; Zhao, X | 1 |
| Barnay, P; Bessereau, J; Bonello, L; Bultez, B; Chelini, V; Fournier, N; Gaubert, M; Gramond, C; Laine, M; Maillard, L; Mokrani, Z; Paganelli, F; Richard, T | 1 |
| Caldeira, D; Ferreira, JJ; Pinto, FJ | 1 |
| Ge, J; Qian, J; Wang, Q; Wu, H; Zhou, J | 1 |
| Parodi, G; Storey, RF | 1 |
| Lenti, MC; Lombardi, N; Matucci, R; Mugelli, A; Vannacci, A | 1 |
| Cambronero-Sánchez, F; Flores-Blanco, PJ; Gómez-Molina, M; Guerrero-Pérez, E; López-Cuenca, A; Manzano-Fernández, S; Sánchez-Galian, MJ; Sánchez-Martínez, M; Valdés, M | 1 |
| DeKoven, M; Effron, MB; Frech-Tamas, F; Karkare, S; Larmore, C; Lu, J; Marrett, E; McCollam, P; Molife, C; Vetrovec, GW; Zhu, Y | 1 |
| Chan, MK; Chan, WS; Shiu, CK; Tsang, KH | 1 |
| Braun, OÖ; Christersson, C; Grove, EL; Halvorsen, S; James, SK; Lindholm, D; Storey, RF; Varenhorst, C | 1 |
| Andell, P; Cannon, CP; Cyr, DD; Erlinge, D; Himmelmann, A; Husted, S; James, SK; Keltai, M; Koul, S; Santoso, A; Steg, PG; Storey, RF; Wallentin, L | 1 |
| Ferro, A | 1 |
| Healy, S; Tung, MK | 1 |
| Cherian, T; Devlin, G; Green, SA; Lee, M | 1 |
| Aylward, PE; Bhatt, DL; Bonaca, MP; Braunwald, E; Budaj, A; Cohen, M; Dalby, AJ; Hamm, C; Held, P; Im, K; Jensen, EC; Kiss, RG; Kontny, F; Kuder, J; Magnani, G; Medina, FA; Oude Ophuis, T; Sabatine, MS; Špinar, J; Steg, PG; Storey, R; Theroux, P | 1 |
| Emdin, M; Giannoni, A; Passino, C | 1 |
| Chung, BB; Minner, SA; Shah, AP; Simone, P | 1 |
| Alexopoulos, D; Barampoutis, N; Deftereos, S; Giannopoulos, G; Goudevenos, J; Hamilos, M; Kanakakis, I; Lekakis, J; Perperis, A; Sitafidis, G; Vavouranakis, M; Xanthopoulou, I | 1 |
| Burgstahler, C; Claussen, CD; Doering, J; Doesch, C; Gawaz, M; Herdeg, C; May, AE; Miller, S; Seeger, A | 1 |
| Nagel, E | 1 |
| Becker, RC; Budaj, A; Cannon, CP; Emanuelsson, H; Freij, A; Harrington, RA; Held, C; Horrow, J; Husted, S; James, S; Katus, H; Mahaffey, KW; Scirica, BM; Skene, A; Steg, PG; Storey, RF; Thorsén, M; Wallentin, L | 1 |
| Tomoda, H | 1 |
| Bliden, KP; Butler, K; Ecob, R; Gurbel, PA; Karunakaran, A; Patil, SB; Storey, RF; Tantry, US; Teng, R; Wei, C | 1 |
| Abergel, E; Nikolsky, E | 1 |
| Guo, KW; Hsu, LF; Tan, JK | 1 |
| Becker, RC; Cairns, R; Cannon, CP; Cools, F; Cooper, A; Emanuelsson, H; Harrington, RA; Husted, S; James, SK; Khurmi, NS; Steg, PG; Storey, RF; Wallentin, L | 1 |
| Colucci, VJ; Crouch, MA; Howard, PA; Spinler, SA | 1 |
| Burgess, S; Juergens, CP; Mallard, TA | 1 |
| Lincoff, AM; May, CH | 1 |
| DiNicolantonio, JJ; Serebruany, VL | 1 |
| Serebruany, VL | 2 |
| Cattaneo, M; Faioni, EM | 1 |
| Ali, S; Gouin, S | 1 |
| Burki, NK; Dale, WJ; Lee, LY | 1 |
| Parra R, C; Uriarte G de C, P; Wainstein G, E; Zagolin B, M | 1 |
| Alam, M; Burki, NK; Lee, LY | 1 |
| Atar, D; Serebruany, VL; Stebbing, J | 1 |
| Burki, NK; Lee, LY; Sheatt, M | 1 |
| Husted, S; van Giezen, JJ | 1 |
| Al-Dahhak, R; Dickerson, JA; Raman, SV | 1 |
| Bouvier, F; Höjer, J; Hulting, J; Jensen-Urstad, M; Ruiz, H; Samad, B | 1 |
| Dietrich, A; Endom, E; Losek, JD; Smith, K; Stewart, G; Zempsky, W | 1 |
| Balan, KK; Critchley, M | 1 |
11 review(s) available for adenosine and Dyspnea
| Article | Year |
|---|---|
Ticagrelor in modern cardiology - an up-to-date review of most important aspects of ticagrelor pharmacotherapy.
Topics: Acute Coronary Syndrome; Adenosine; Cytochrome P-450 CYP2C19; Drug Interactions; Dyspnea; Half-Life; Hemorrhage; Humans; Pharmacogenetics; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticagrelor | 2018 |
Potential role of endogenous adenosine in ticagrelor-induced dyspnea.
Topics: Adenosine; Dyspnea; Humans; Platelet Aggregation Inhibitors; Ticagrelor | 2013 |
Dyspnea and reversibility of antiplatelet agents: ticagrelor, elinogrel, cangrelor, and beyond.
Topics: Acute Lung Injury; Adenosine; Adenosine Monophosphate; Administration, Oral; Clopidogrel; Dyspnea; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Quinazolinones; Randomized Controlled Trials as Topic; Sulfonamides; Ticagrelor; Ticlopidine; Transfusion Reaction | 2014 |
[New antiplatelet drugs in coronary artery disease].
Topics: Adenosine; Adenosine Monophosphate; Clinical Trials, Phase III as Topic; Coronary Artery Disease; Double-Blind Method; Dyspnea; Hemorrhage; Humans; Multicenter Studies as Topic; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Receptors, Proteinase-Activated; Thiophenes; Ticagrelor; Treatment Outcome | 2014 |
Dyspnea and reversibility profile of P2Y₁₂ antagonists: systematic review of new antiplatelet drugs.
Topics: Adenosine; Adenosine Monophosphate; Clopidogrel; Dyspnea; Humans; Incidence; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Quinazolinones; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Sulfonamides; Thiophenes; Ticagrelor; Ticlopidine | 2014 |
Dyspnoea management in acute coronary syndrome patients treated with ticagrelor.
Topics: Acute Coronary Syndrome; Adenosine; Dyspnea; Humans; Purinergic P2Y Receptor Antagonists; Ticagrelor | 2015 |
Ticagrelor: an investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Blood Platelets; Clopidogrel; Dyspnea; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Ticagrelor; Ticlopidine; Treatment Outcome | 2010 |
Review of ticagrelor in the management of acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adenosine; Clopidogrel; Dyspnea; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine | 2012 |
Safety profile and bleeding risk of ticagrelor compared with clopidogrel.
Topics: Acute Coronary Syndrome; Adenosine; Clopidogrel; Dyspnea; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Risk Factors; Ticagrelor; Ticlopidine | 2012 |
Why does ticagrelor induce dyspnea?
Topics: Adenosine; Clopidogrel; Dyspnea; Humans; Models, Biological; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Sensory Receptor Cells; Ticagrelor; Ticlopidine | 2012 |
Dyspnoea after antiplatelet agents: the AZD6140 controversy.
Topics: Adenosine; Dyspnea; Humans; Platelet Aggregation Inhibitors; Ticagrelor | 2007 |
12 trial(s) available for adenosine and Dyspnea
| Article | Year |
|---|---|
Adenosine and Ticagrelor Plasma Levels in Patients With and Without Ticagrelor-Related Dyspnea.
Topics: Acute Coronary Syndrome; Adenosine; Biomarkers; Cross-Over Studies; Drug Monitoring; Dyspnea; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; Ticagrelor; Time Factors | 2018 |
Caffeine and incidence of dyspnea in patients treated with ticagrelor.
Topics: Adenosine; Aged; Caffeine; Drug Monitoring; Dyspnea; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Patient Reported Outcome Measures; Purinergic P2Y Receptor Antagonists; Ticagrelor | 2018 |
Intravenous adenosine activates diffuse nociceptive inhibitory controls in humans.
Topics: Adenosine; Adult; Carbon Dioxide; Chest Pain; Cross-Over Studies; Double-Blind Method; Dyspnea; Electric Stimulation; Healthy Volunteers; Humans; Male; Middle Aged; Nerve Fibers, Unmyelinated; Neural Inhibition; Neural Pathways; Nociceptors; Pain Measurement; Reflex; Young Adult | 2013 |
Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOr.
Topics: Acute Coronary Syndrome; Adenosine; Caffeine; Dose-Response Relationship, Drug; Double-Blind Method; Dyspnea; Electrocardiography; Purinergic P1 Receptor Antagonists; Purinergic P2Y Receptor Antagonists; Ticagrelor | 2015 |
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Dyspnea; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Risk Factors; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome | 2015 |
Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events: A Secondary Analysis of the PEGASUS-TIMI 54 Trial.
Topics: Adenosine; Dyspnea; Hemorrhage; Humans; Myocardial Infarction; Purinergic P2Y Receptor Antagonists; Quality of Life; Secondary Prevention; Stroke; Ticagrelor | 2016 |
Ticagrelor versus clopidogrel in patients with acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Double-Blind Method; Dyspnea; Electrocardiography; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Stroke; Ticagrelor; Ticlopidine | 2009 |
Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study.
Topics: Adenosine; Aged; Aspirin; Clopidogrel; Coronary Disease; Double-Blind Method; Dyspnea; Female; Heart; Humans; Lung; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Ticagrelor; Ticlopidine | 2010 |
Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Double-Blind Method; Dyspnea; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine; Treatment Outcome | 2011 |
Intravenous adenosine and dyspnea in humans.
Topics: Adenosine; Adolescent; Adult; Dyspnea; Female; Hand Strength; Heart Rate; Humans; Hyperoxia; Injections, Intravenous; Male; Middle Aged; Pulmonary Ventilation | 2005 |
The pulmonary effects of intravenous adenosine in asthmatic subjects.
Topics: Adenosine; Adult; Asthma; Bronchial Spasm; Dose-Response Relationship, Drug; Dyspnea; Female; Humans; Injections, Intravenous; Lung; Male; Respiratory Mechanics | 2006 |
Effects of airway anesthesia on dyspnea and ventilatory response to intravenous injection of adenosine in healthy human subjects.
Topics: Adenosine; Administration, Inhalation; Adolescent; Adult; Airway Resistance; Anesthetics, Local; Dyspnea; Female; Heart Rate; Humans; Lidocaine; Male; Middle Aged; Nucleosides; Pulmonary Ventilation | 2008 |
34 other study(ies) available for adenosine and Dyspnea
| Article | Year |
|---|---|
An insidious coronary arterial pathology diagnosed with an adenosine stress computed tomography perfusion study.
Topics: Adenosine; Coronary Vessels; Dyspnea; Humans; Male; Myocardial Bridging; Myocardial Perfusion Imaging; Tomography, X-Ray Computed; Young Adult | 2020 |
Wide Complex Tachycardia in an Elderly Woman.
Topics: Accessory Atrioventricular Bundle; Adenosine; Aged; Anti-Arrhythmia Agents; Bundle-Branch Block; Chest Pain; Dyspnea; Echocardiography; Electrocardiography; Female; Humans; Mitral Valve Insufficiency; Stroke Volume; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Supraventricular | 2017 |
Microvascular Angina - Long-Term Exercise Stress Test Follow-up.
Topics: Adenosine; Adult; Coronary Circulation; Dyspnea; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Ischemia; Male; Microvascular Angina; Middle Aged; Nitroglycerin | 2018 |
Associations of AMP and adenosine induced dyspnea sensation to large and small airways dysfunction in asthma.
Topics: Adenosine; Adenosine Monophosphate; Adult; Asthma; Bronchi; Bronchial Provocation Tests; Bronchoconstrictor Agents; Dyspnea; Female; Forced Expiratory Volume; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Spirometry | 2019 |
Left ventricular non-compaction; an unusual presentation with supraventricular tachycardia in the emergency department.
Topics: Adenosine; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dyspnea; Emergency Service, Hospital; Humans; Male; Middle Aged; Tachycardia, Supraventricular; Treatment Refusal; Ventricular Dysfunction, Left | 2019 |
Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009.
Topics: Adenosine; Age Factors; Aged; Angina, Stable; Body Mass Index; Cardiotonic Agents; Coronary Artery Disease; Diabetes Mellitus; Dyspnea; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Hospitalization; Humans; Hypertension; Logistic Models; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Prospective Studies; Sex Factors; Smoking; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2013 |
Effects of intracoronary sodium nitroprusside compared with adenosine on fractional flow reserve measurement.
Topics: Adenosine; Adult; Aged; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Dyspnea; Flushing; Fractional Flow Reserve, Myocardial; Headache; Hemodynamics; Humans; Hyperemia; Incidence; Injections, Intra-Arterial; Middle Aged; Nitroprusside; Severity of Illness Index | 2014 |
Effect of ticagrelor-related dyspnea on compliance with therapy in acute coronary syndrome patients.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Dyspnea; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Middle Aged; Prospective Studies; Purinergic P2Y Receptor Antagonists; Ticagrelor; Treatment Outcome | 2014 |
First report of stent thrombosis after a switch therapy resulting from ticagrelor-related dyspnea.
Topics: Adenosine; Aged; Clopidogrel; Drug Substitution; Dyspnea; Humans; Male; Purinergic P2Y Receptor Antagonists; Stents; Thrombosis; Ticagrelor; Ticlopidine | 2014 |
Ticagrelor-related dyspnea: an underestimated and poorly managed event?
Topics: Acute Coronary Syndrome; Adenosine; Dyspnea; Female; Humans; Male; Medication Adherence; Purinergic P2Y Receptor Antagonists | 2015 |
Ticagrelor related dyspnea in patients with acute coronary syndromes: Incidence and implication on ticagrelor withdrawn.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Dyspnea; Female; Humans; Incidence; Male; Middle Aged; Purinergic P2Y Receptor Antagonists; Registries; Retrospective Studies; Ticagrelor | 2015 |
Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelor.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Dyspnea; Female; Health Services; Hemorrhage; Humans; Length of Stay; Male; Middle Aged; Patient Readmission; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Propensity Score; Ticagrelor | 2015 |
The safety and tolerability of adenosine as a pharmacological stressor in stress perfusion cardiac magnetic resonance imaging in the Chinese population.
Topics: Adenosine; Adolescent; Adult; Aged; Aged, 80 and over; Asian People; Blood Pressure; Chest Pain; Child; Coronary Artery Disease; Dyspnea; Female; Headache; Heart Rate; Hemodynamics; Hong Kong; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Prospective Studies; Vasodilator Agents; Young Adult | 2015 |
Newer antiplatelet agents in acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Drug Therapy, Combination; Dyspnea; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Ticagrelor; Treatment Outcome | 2016 |
IMAGES IN CLINICAL MEDICINE. Cannon A Waves.
Topics: Adenosine; Aged; Anti-Arrhythmia Agents; Catheter Ablation; Dyspnea; Electrocardiography; Humans; Male; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Supraventricular | 2016 |
Ticagrelor in the Real World: The Midland Regional Cardiac Network Experience.
Topics: Adenosine; Aged; Aspirin; Cohort Studies; Dyspnea; Female; Hemorrhage; Humans; Male; Medication Adherence; Myocardial Infarction; Patient Satisfaction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Ticagrelor | 2015 |
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea.
Topics: Adenosine; Cheyne-Stokes Respiration; Dyspnea; Humans; Hypercapnia; Myocardial Infarction; Purinergic P2Y Receptor Antagonists; Respiratory Function Tests; Ticagrelor | 2016 |
Successful Reversal of Bradycardia and Dyspnea With Aminophylline After Ticagrelor Load.
Topics: Adenosine; Aged; Aminophylline; Bradycardia; Dyspnea; Humans; Male; Purinergic P1 Receptor Antagonists; Purinergic P2Y Receptor Antagonists; Ticagrelor | 2018 |
Dyspnea in patients treated with P2Y
Topics: Acute Coronary Syndrome; Adenosine; Dyspnea; Female; Greece; Hematocrit; Hemorrhage; Humans; Male; Middle Aged; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Registries; Risk Factors; Ticagrelor; Ticlopidine | 2017 |
Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity.
Topics: Adenosine; Aged; Angina Pectoris; Cardiovascular Diseases; Coronary Stenosis; Dyspnea; Female; Humans; Kaplan-Meier Estimate; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Patient Selection; Predictive Value of Tests; Proportional Hazards Models; Radiography; Risk Assessment; Severity of Illness Index; Time Factors; Treatment Outcome; Vasodilator Agents | 2009 |
Taking the last hurdles: magnetic resonance myocardial perfusion imaging.
Topics: Adenosine; Angina Pectoris; Cardiovascular Diseases; Coronary Stenosis; Dyspnea; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Myocardial Perfusion Imaging; Patient Selection; Predictive Value of Tests; Radiography; Risk Assessment; Severity of Illness Index; Time Factors; Treatment Outcome; Vasodilator Agents | 2009 |
Ticagrelor versus clopidogrel in acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adenosine; Clopidogrel; Dyspnea; Humans; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Ticagrelor; Ticlopidine | 2009 |
Palpitations and narrow-complex tachycardia.
Topics: Adenosine; Diagnosis, Differential; Dyspnea; Electric Countershock; Electrocardiography; Humans; Hypertension; Male; Middle Aged; Parkinson Disease; Tachycardia; Treatment Outcome | 2011 |
P2Y₁₂ receptor inhibitors: integrating ticagrelor into the management of acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adenosine; Algorithms; Dyspnea; Humans; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticagrelor | 2011 |
Angiotensin receptor blockers worsen renal function and dyspnea on ticagrelor: a potential ticagrelor-angiotensin receptor blocker interaction?
Topics: Adenosine; Angiotensin II Type 1 Receptor Blockers; Clopidogrel; Drug Interactions; Dyspnea; Glomerular Filtration Rate; Hemorrhage; Humans; Kidney; Kidney Diseases; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Ticagrelor; Ticlopidine; United States; United States Food and Drug Administration | 2012 |
Viewpoint: reversible nature of platelet binding causing transfusion-related acute lung injury (TRALI) syndrome may explain dyspnea after ticagrelor and elinogrel.
Topics: Acute Lung Injury; Adenosine; Blood Platelets; Dyspnea; Humans; Models, Biological; Platelet Aggregation Inhibitors; Quinazolinones; Sulfonamides; Syndrome; Ticagrelor; Transfusion Reaction | 2012 |
A patient with chaotic atrial tachycardia.
Topics: Abnormalities, Multiple; Adenosine; Anti-Asthmatic Agents; Asthma; Bronchiolitis; Combined Modality Therapy; Diagnosis, Differential; Dyspnea; Electroencephalography; Emergencies; Female; Fluid Therapy; Furosemide; Heart Failure; Heart Septal Defects, Atrial; Humans; Infant; Procainamide; Recurrence; Tachycardia; Tachycardia, Ectopic Atrial | 2003 |
Dyspnoea after AZD6140: safety first?
Topics: Adenosine; Clinical Trials, Phase II as Topic; Dyspnea; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticagrelor | 2006 |
[Clinical, functional and hemodynamic features of patients with pulmonary arterial hypertension].
Topics: Adenosine; Adolescent; Adult; Aged; Dyspnea; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Prognosis; Prospective Studies; Pulmonary Wedge Pressure; Severity of Illness Index; Statistics, Nonparametric; Vasodilator Agents | 2006 |
Dyspnoea and antiplatelet agents: revisited.
Topics: Adenosine; Dyspnea; Humans; Purinergic P2 Receptor Antagonists; Ticagrelor | 2007 |
Myocardial ischemia in the absence of epicardial coronary artery disease in Friedreich's ataxia.
Topics: Adenosine; Adult; Angina Pectoris; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Dyspnea; Female; Friedreich Ataxia; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Microcirculation; Myocardial Ischemia; Pericardium; Vasodilator Agents | 2008 |
Myocardial perfusion scintigraphy (SPECT) during adenosine stress can be performed safely early on after thrombolytic therapy in acute myocardial infarction.
Topics: Adenosine; Aged; Dyspnea; Electrocardiography; Exercise Test; Female; Heart Block; Heart Rate; Humans; Hyperemia; Male; Middle Aged; Myocardial Infarction; Technetium Tc 99m Sestamibi; Thrombolytic Therapy; Tomography, Emission-Computed, Single-Photon | 1998 |
Adenosine and pediatric supraventricular tachycardia in the emergency department: multicenter study and review.
Topics: Adenosine; Adolescent; Anti-Arrhythmia Agents; Bradycardia; Child; Child, Preschool; Dyspnea; Emergency Service, Hospital; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Retrospective Studies; Tachycardia, Ventricular; Treatment Outcome; Vomiting | 1999 |
Is the dyspnea during adenosine cardiac stress test caused by bronchospasm?
Topics: Adenosine; Bronchial Spasm; Dyspnea; Female; Heart Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Radionuclide Imaging; Spirometry | 2001 |